INTERNATIONAL PATENT: BOLD THERAPEUTICS INC. FILES APPLICATION FOR "USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] FOR TREATING TP53 MUTANT CANCERS"

GENEVA, April 26 -- BOLD THERAPEUTICS INC. (850 West Hastings Street, Suite 515Vancouver, British Columbia V6C 1E1) filed a patent application (PCT/CA2025/051370) for "USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] FOR TREATING TP53 MUTANT CANCERS" on Oct 17, 2025. With publication no. WO/2026/081019, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAZETT, Mark (c/o 850 West Hastings Street, Suite 515Vancouver, British Columbia V6C 1E1), PARK, Brian (c/o 850 West Hastings Street, Suite 515Vancouver, Bri...